Literature DB >> 22793852

Clinical features of HPV-related head and neck squamous cell carcinoma: presentation and work-up.

Wayne M Koch1.   

Abstract

Head and neck squamous cell carcinoma (HNSCC) that arises as a result of the activity of human papillomavirus (HPV) malignant transformation has a distinct disease pattern that is the basis for its clinical presentation. A clear understanding of these distinct clinical features enables diagnosticians to maintain awareness and index of suspicion to avoid delays in detection and select the most effective and thorough measures of evaluating the disease and directing treatment selection. Attention is focused on the broader demographic at risk for developing HPV-related HNSCC, the phenomenon of cystic cervical nodal metastases, and the unknown or occult primary cancer.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22793852     DOI: 10.1016/j.otc.2012.04.004

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  11 in total

1.  Galectin-3 Expression in High-Risk HPV-Positive and Negative Head & Neck Squamous Cell Carcinomas and Regional Lymph Node Metastases.

Authors:  Joseph D Coppock; Anne M Mills; Edward B Stelow
Journal:  Head Neck Pathol       Date:  2020-06-20

2.  FDG PET/CT imaging of oropharyngeal squamous cell carcinoma: characteristics of human papillomavirus-positive and -negative tumors.

Authors:  Abdel K Tahari; Krishna C Alluri; Harry Quon; Wayne Koch; Richard L Wahl; Rathan M Subramaniam
Journal:  Clin Nucl Med       Date:  2014-03       Impact factor: 7.794

3.  The use of ultrasound in the search for the primary site of unknown primary head and neck squamous cell cancers.

Authors:  Carole Fakhry; Nishant Agrawal; Joseph Califano; Barbara Messing; Jia Liu; John Saunders; Patrick Ha; Stephanie Coquia; Ulrike Hamper; Maura Gillison; Ray Blanco
Journal:  Oral Oncol       Date:  2014-05-10       Impact factor: 5.337

Review 4.  The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas.

Authors:  Eleni Benson; Ryan Li; David Eisele; Carole Fakhry
Journal:  Oral Oncol       Date:  2013-10-14       Impact factor: 5.337

5.  Proteomic study of HPV-positive head and neck cancers: preliminary results.

Authors:  Géraldine Descamps; Ruddy Wattiez; Sven Saussez
Journal:  Biomed Res Int       Date:  2014-03-02       Impact factor: 3.411

6.  Optical coherence tomography and autofluorescence imaging of human tonsil.

Authors:  Hamid Pahlevaninezhad; Anthony M D Lee; Miriam Rosin; Ivan Sun; Lewei Zhang; Mehrnoush Hakimi; Calum MacAulay; Pierre M Lane
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

7.  mTOR inhibition as an adjuvant therapy in a metastatic model of HPV+ HNSCC.

Authors:  Joseph D Coppock; Paola D Vermeer; Daniel W Vermeer; Kimberly M Lee; W Keith Miskimins; William C Spanos; John H Lee
Journal:  Oncotarget       Date:  2016-04-26

Review 8.  mTOR, metabolism, and the immune response in HPV-positive head and neck squamous cell cancer.

Authors:  Joseph D Coppock; John H Lee
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2016-07-20

Review 9.  Advancements in the Management of HPV-Associated Head and Neck Squamous Cell Carcinoma.

Authors:  Ross Zeitlin; Harrison P Nguyen; David Rafferty; Stephen Tyring
Journal:  J Clin Med       Date:  2015-04-24       Impact factor: 4.241

10.  Transcervical ultrasonography is feasible to visualize and evaluate base of tongue cancers.

Authors:  Ray Gervacio F Blanco; Joseph Califano; Barbara Messing; Jeremy Richmon; Jia Liu; Harry Quon; Geoffrey Neuner; John Saunders; Patrick K Ha; Sheila Sheth; Maura Gillison; Carole Fakhry
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.